Ryman Healthcare Ltd
F:RH7
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Intrinsic Value
The intrinsic value of
Ryman Healthcare Ltd (RH7) under the Base Case is 0.8673 EUR per share.
Compared with the current market price of 0.8705 EUR, the stock appears
Fairly Valued .
The intrinsic value is calculated using the DCF method.
Do our valuations actually work? See backtest results .
Fundamental Analysis
What Ryman Healthcare Does
Ryman Healthcare builds, owns, and runs retirement villages and aged-care homes for older adults, mainly in New Zealand and Australia. It offers independent living units, serviced apartments, and care beds, so residents can move from lighter support to more intensive care within the same community as their needs change.
- Headquarters
- New Zealand NZ
- Employees
- 7 800
- IPO date
- Jun 25, 1999
Ryman Healthcare has no economic moat
Ryman Healthcare Ltd lacks an economic moat, leaving it vulnerable to competitive pressures and market challenges.
Read the full moat analysisContinue RH7 Research
Decided on Ryman Healthcare? Get an email when RH7 reaches the price you’d buy at. Free with an account.
Other Ryman Healthcare listings
What is the Intrinsic Value of one RH7 stock?
The intrinsic value for
Ryman Healthcare Ltd (RH7) under the Base Case is 0.8673 EUR.
Is RH7 stock undervalued or overvalued?
Compared with the current market price of 0.8705 EUR, the stock appears Fairly Valued .